HC Wainwright & Co. Reiterates Neutral on Lipocine, Announces $4 Price Target

Benzinga · 2d ago
HC Wainwright & Co. analyst Yi Chen reiterates Lipocine (NASDAQ:LPCN) with a Neutral and announces $4 price target.